Episode 67: The ER Perspective on COVID-19 With Seth Trueger
Seth Trueger, ER physician shares the steps taken in an emergency room setting to prepare for an influx of patients.
Topic: Outspoken Oncology Episodes
Episode 66: COVID-19 Policy Implications and Preliminary Clinical Data With Emily Landon
Emily Landon returns to discuss crucial considerations for reopening the country.
Episode 65: Physician Perspectives on Reopening the Country
Multiple myeloma specialists at Mayo Clinic, discuss the prospect of opening the country before a vaccine is developed for COVID-19.
Episode 64: Ethical Dilemmas of COVID-19 With Alison Bateman-House
Alison Bateman-House returns to discuss the ethics of “expanded access” and “Right To Try” when treating COVID-19.
Episode 63: Update From the COVID-19 Nursing Frontline
Nurses join Chadi to discuss COVID-19 at their institutions.
Episode 62: Treatment, Testing, and Transmission Updates With Emily Landon
Emily Landon, MD returns for her fourth update on COVID-19
Episode 60: Drug Shortages, Supply Chain, and Pharmacies During COVID-19
Niesha Griffith and Michael Ganio provide varying perspectives on the potential of drug shortages (eg, pain medications, cancer therapies, and hydroxychloroquine) emerging during the COVID-19 pandemic, as well as how the supply chain functions through the ASHP when a shortage is identified.
Episode 59: Economic Fallout of COVID-19 With Cam Harvey
Cam Harvey, PhD, professor of finance, Duke University, shares how his June 2019 prediction of a recession in 2020 is being further fueled by COVID-19, compares the pandemic to the likes of the Spanish Flu and SARS in terms of “systemic risk,” breaks down the finances of the recently enacted CARES Act, floats the idea of a federal strategic medical equipment reserve, and more.